About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COVID-19 and Childhood Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNCT06482281

COVID-19 and Childhood Cancer

The investigators will first examine the impact of the COVID-19 pandemic on childhood cancer patients in Sweden and Denmark, both regarding susceptibility to severe COVID-19 among long-term childhood ...

Lead sponsor: Karolinska Institutet•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Karolinska Institutet

Collaborators

The Swedish Research Council
The Swedish Childhood Cancer Fund

Age

0 - 19 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Childhood cancer cases (age 0-19) diagnosed from 1971 in Sweden and Denmark who were alive five years after diagnosis
•Two different comparisons groups: five age- and sex-matched comparisons for each childhood cancer survivor as well as all siblings of the childhood cancer survivors.
•All childhood cancer survivors, matched comparisons, and siblings of the survivors should be 20+ at the start of 2020.
•\- All children (age 0-19) diagnosed with cancer from 2015 in Sweden and Denmark

Related studies

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

NCT05582551 · Childhood Cancer

Viral Infections in Healthy and Immunocompromised Hosts

NCT01306084 · Anogenital Herpes, COVID-19, and more

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

NCT04551378 · COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, and more

REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

NCT05218083 · COVID-19, Critical Illness, and more

Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

NCT05078905 · COVID-19, Vaccination, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 3, 2024Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment100,000

Start dateJan 2023

Last updatedJul 3, 2024

Condition

COVID-19 Childhood Cancer Childhood Leukemia, Acute Lymphoblastic

Locations shown

Karolinska Institutet

Stockholm

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 3, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions